Zacks: Brokerages Anticipate MaxLinear, Inc. (MXL) Will Announce Quarterly Sales of $114.26 Million

Analysts expect MaxLinear, Inc. (NYSE:MXL) to post sales of $114.26 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for MaxLinear’s earnings, with estimates ranging from $114.00 million to $115.00 million. MaxLinear posted sales of $87.14 million in the same quarter last year, which suggests a positive year-over-year growth rate of 31.1%. The firm is expected to announce its next quarterly earnings report after the market closes on Tuesday, February 13th.

On average, analysts expect that MaxLinear will report full year sales of $114.26 million for the current financial year, with estimates ranging from $420.60 million to $426.25 million. For the next year, analysts anticipate that the company will post sales of $511.84 million per share, with estimates ranging from $508.10 million to $516.10 million. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that cover MaxLinear.

MaxLinear (NYSE:MXL) last released its earnings results on Tuesday, November 7th. The semiconductor company reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.06. MaxLinear had a return on equity of 20.96% and a net margin of 4.73%. The firm had revenue of $113.58 million during the quarter, compared to analysts’ expectations of $115.77 million. During the same quarter last year, the business posted $0.43 earnings per share. The firm’s revenue was up 17.9% on a year-over-year basis.

Several research firms recently issued reports on MXL. Zacks Investment Research cut MaxLinear from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, January 10th. Roth Capital reiterated a “buy” rating and set a $33.00 target price on shares of MaxLinear in a research report on Friday, December 29th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $32.00 target price on shares of MaxLinear in a research report on Wednesday, November 8th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. MaxLinear currently has an average rating of “Buy” and a consensus price target of $31.60.

In related news, VP Brendan Walsh sold 25,018 shares of the stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $28.00, for a total transaction of $700,504.00. Following the completion of the transaction, the vice president now directly owns 155,441 shares of the company’s stock, valued at $4,352,348. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 11.92% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. BlackRock Inc. boosted its stake in MaxLinear by 94.6% during the second quarter. BlackRock Inc. now owns 6,503,231 shares of the semiconductor company’s stock valued at $181,375,000 after buying an additional 3,160,655 shares during the last quarter. UBS Asset Management Americas Inc. boosted its stake in MaxLinear by 30.1% during the second quarter. UBS Asset Management Americas Inc. now owns 37,159 shares of the semiconductor company’s stock valued at $1,036,000 after buying an additional 8,601 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its stake in MaxLinear by 7.0% during the second quarter. Schwab Charles Investment Management Inc. now owns 242,533 shares of the semiconductor company’s stock valued at $6,765,000 after buying an additional 15,960 shares during the last quarter. Great West Life Assurance Co. Can boosted its stake in MaxLinear by 7.6% during the third quarter. Great West Life Assurance Co. Can now owns 81,962 shares of the semiconductor company’s stock valued at $1,962,000 after buying an additional 5,784 shares during the last quarter. Finally, Paradigm Capital Management Inc. NY boosted its stake in MaxLinear by 7.9% during the third quarter. Paradigm Capital Management Inc. NY now owns 1,050,140 shares of the semiconductor company’s stock valued at $24,941,000 after buying an additional 77,180 shares during the last quarter. 88.59% of the stock is owned by institutional investors.

Shares of MaxLinear (MXL) opened at $25.66 on Friday. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.58 and a current ratio of 2.23. MaxLinear has a 1 year low of $20.38 and a 1 year high of $32.47. The stock has a market capitalization of $1,726.85 and a PE ratio of 98.70.

ILLEGAL ACTIVITY WARNING: “Zacks: Brokerages Anticipate MaxLinear, Inc. (MXL) Will Announce Quarterly Sales of $114.26 Million” was first posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2018/02/02/zacks-brokerages-anticipate-maxlinear-inc-mxl-will-announce-quarterly-sales-of-114-26-million.html.

About MaxLinear

MaxLinear, Inc is a provider of radio frequency (RF) and mixed-signal integrated circuits for cable and satellite broadband communications and the connected home, and wired and wireless infrastructure markets. The Company’s RF receiver products capture and process digital and analog broadband signals to be decoded for various applications.

Get a free copy of the Zacks research report on MaxLinear (MXL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for MaxLinear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxLinear and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply